I for one am not concerned about AI prescribing. I am concerned it has not yet reached Texas.
Category: Doctors & Hospitals
Tuesday Links – 10 March 2026
- “By 2022, the US had one of the highest shares of primary care physicians reporting burnout (44 percent). Switzerland (18 percent) and the Netherlands (12 percent) had the lowest shares reporting.”
- Some people 80 and up have the memory ability of someone 30 years younger.
- Moderna’s combo mRNA is effective against three main flu strains plus covid. Th’s Ok in Europe. But not for the FDA? (WSJ)
- Last year’s job gains were due to heath care.
- Chatbot psychosis is real. (WSJ)
- Five leading AI models gave bad medical advice.
Saturday Links – 7 March 2026
- Medical schools to start teaching MAHA approach to nutrition.
- What to know about vaccine mandates, vaccine lawsuits and compensation for vaccine injuries.
- Disappointment at TrumpRx: later, the site has only 44 of the 24,000 prescription drugs that federal regulators have approved.
- If we defunded the police, could we have law enforcement without them?
- More than 40 percent of heath care spending is for shoppable services.
The FDA is Increasingly Skeptical of Therapies for Rare Diseases
The FDA under Trump has consistently maintained its stated goal of removing bureaucratic obstacles to drug approval. FDA commissioner, Marty Makary, announced steps to speed the approval of new drugs, including allowing one well-designed clinical trial rather than two or more trials to show efficacy. Yet, drug companies continue to claim inconsistent guidelines, endpoints changed and a skeptical agency when it comes to rare disease therapies. Recently drugmakers have complained the FDA moved the goalposts, after agreeing to them.